​

Funding Round

Series B - Simcha Therapeutics

Series B - Simcha Therapeutics

Investment Firm

Overview

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

Announced Date

Jan 27, 2022

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

SR One

SR One

SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorRock Springs Capital
Participant InvestorLogos Capital
Participant InvestorBiotechnology Value Fund
Participant InvestorArrowMark Partners
Participant InvestorSR One

Round Details and Background

Simcha Therapeutics raised $40000000 on 2022-01-27 in Series B

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 25, 2020
Series A - Simcha Therapeutics
4-25.0M
Jan 27, 2022
Series B - Simcha Therapeutics
6-40.0M

Recent Activity

There is no recent news or activity for this profile.